We are live on ! Find out more
IUHSA

Itau Unibanco Holding S.A. Portfolio holdings

AUM $4.31B
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+46.57%
3 Year Est. Return
+107.3%
5 Year Est. Return
+125.12%
10 Year Est. Return
+406.64%
AUM
$1.76B
AUM Growth
+$811M
Cap. Flow
+$770M
Cap. Flow %
43.89%
Top 10 Hldgs %
59.17%
Holding
851
New
108
Increased
186
Reduced
281
Closed
263

Sector Composition

Rank Sector Weight
1 Financials 18.68%
2 Energy 8.12%
3 Materials 6.49%
4 Communication Services 5.43%
5 Technology 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
551
DELISTED
Revance Therapeutics, Inc.
RVNC
$44K ﹤0.01%
1,768
-147
-8% -$4K
SKX
552
DELISTED
Skechers
SKX
$41K ﹤0.01%
1,457
-2,986
-67% -$86.5K
ARD
553
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$40K ﹤0.01%
2,367
-364
-13% -$5.93K
RARX
554
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$38K ﹤0.01%
2,119
-54
-2% -$640
BHVN
555
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$37K ﹤0.01%
988
-64
-6% -$2.35K
J icon
556
Jacobs Solutions
J
$17.3B
$36K ﹤0.01%
+562
New +$33K
BOLD
557
DELISTED
Audentes Therapeutics, Inc
BOLD
$36K ﹤0.01%
921
-21
-2% -$783
AGCO icon
558
AGCO
AGCO
$7.03B
$34K ﹤0.01%
556
-502
-47% -$30.4K
REGN icon
559
Regeneron Pharmaceuticals
REGN
$83.2B
$34K ﹤0.01%
83
-411
-83% -$156K
GTHX
560
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$34K ﹤0.01%
657
+177
+37% +$9.65K
FTSV
561
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$34K ﹤0.01%
+2,282
New +$34K
FMC icon
562
FMC
FMC
$1.29B
$30K ﹤0.01%
+397
New +$29.9K
NBL
563
DELISTED
Noble Energy, Inc.
NBL
$29K ﹤0.01%
+941
New +$30.1K
ONCE
564
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$25K ﹤0.01%
+460
New +$31.5K
TSRO
565
DELISTED
TESARO, Inc.
TSRO
$25K ﹤0.01%
642
-15
-2% -$530
KDNY
566
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$24K ﹤0.01%
646
-16
-2% -$514
HRTX icon
567
Heron Therapeutics
HRTX
$64.3M
$22K ﹤0.01%
693
+380
+121% +$14.2K
GBT
568
DELISTED
Global Blood Therapeutics, Inc.
GBT
$22K ﹤0.01%
585
-219
-27% -$9.7K
RDUS
569
DELISTED
Radius Health, Inc.
RDUS
$21K ﹤0.01%
+1,167
New +$26.4K
TEAM icon
570
Atlassian
TEAM
$38.7B
$20K ﹤0.01%
+207
New +$16.4K
ASMB icon
571
Assembly Biosciences
ASMB
$531M
$19K ﹤0.01%
+44
New +$20.6K
SNDX icon
572
Syndax Pharmaceuticals
SNDX
$1.81B
$19K ﹤0.01%
2,388
-868
-27% -$6.19K
CELG
573
DELISTED
Celgene Corp
CELG
$18K ﹤0.01%
205
-4,909
-96% -$434K
KALA icon
574
KALA BIO
KALA
$14.2M
$16K ﹤0.01%
1
HUBS icon
575
HubSpot
HUBS
$10.8B
$15K ﹤0.01%
100
-1,110
-92% -$153K

Similar funds

Itau Unibanco Holding S.A.'s Q3 2018 Portfolio in Review

As of Q3 2018, Itau Unibanco Holding S.A. held 851 positions worth $1.76B, up 86% from $945M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Itau Unibanco Holding S.A. deployed $770M of net new capital in Q3 2018, opening 108 new positions and adding to 186 existing holdings. Its largest new stake was Itaú Unibanco: 8,760,127 shares worth $46.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 9.8% a quarter earlier, followed by Energy and Materials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $97.2M trimmed.

  • Itau Unibanco Holding S.A.'s largest Q3 2018 buy was Itaú Unibanco: 8,760,127 shares worth $46.7M.
  • Itau Unibanco Holding S.A. added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $257M increase.
  • Itau Unibanco Holding S.A.'s biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $97.2M.
  • Itau Unibanco Holding S.A. fully exited Azul in Q3 2018, selling an estimated $1.67M.
  • Itau Unibanco Holding S.A.'s ten largest holdings make up 59% of its $1.76B portfolio in Q3 2018.
  • Itau Unibanco Holding S.A. opened 108 new positions and closed 263 in Q3 2018.
  • Itau Unibanco Holding S.A.'s portfolio value rose 86% quarter-over-quarter to $1.76B.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2018, filed 13 Nov 2018.